+467.0%
MRNA vs FCEL
+180.7%
+286.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FCEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.9% | +3.5% | +5.2% |
| 7D | -1.1% | +6.3% | -7.4% | -1.7% |
| 30D | +126.1% | -26.7% | +152.8% | +130.4% |
| 3M | +190.0% | -10.2% | +200.2% | +181.9% |
| 6M | +157.2% | +123.5% | +33.7% | +112.2% |
| YTD | +388.2% | +117.4% | +270.8% | +304.7% |
| 1Y | +467.0% | +146.0% | +321.1% | +337.1% |
| All | +467.0% | +180.7% | +286.3% | +337.1% |
Cumulative growth
Daily Returns
Daily percentage return beside FCEL.
Daily Out/Under-Performance
Portfolio return minus FCEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FCEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling